Glucose-Responsive Vesicles in Microneedle Arrays for Insulin Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current insulin delivery systems for diabetes management are invasive, painful, and lack rapid glucose responsiveness, often causing localized inflammation and inadequate glucose control.
Innovation Solution
Development of glucose-sensitive vesicles and microneedle arrays comprising an amphiphilic polymer conjugated with hydrogen peroxide-sensitive and hypoxia-sensitive moieties, encapsulating insulin and glucose oxidase, which disassemble in response to high glucose levels to release insulin, eliminating excess hydrogen peroxide and avoiding inflammation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If traditional insulin injection methods are used, then insulin delivery is achieved, but the process is invasive and painful
Solution Approach 1:
The patent uses microneedle arrays with thin film structures that dissolve or penetrate the skin barrier to deliver insulin. The microneedles are sufficiently thin to minimize pain and invasion while still effectively delivering insulin through the skin, resolving the contradiction between delivery effectiveness and patient comfort.
Solution Approach 2:
The patent replaces traditional mechanical injection systems with glucose-responsive vesicles that automatically release insulin through chemical sensing mechanisms. The vesicles contain glucose oxidase that detects glucose levels and triggers insulin release, eliminating the need for mechanical injection devices and reducing pain and invasion.
2Speed
If traditional insulin delivery systems are used, then insulin is delivered, but rapid glucose responsiveness is lacking
Solution Approach 1:
The patent implements a feedback mechanism where glucose oxidase within the vesicles continuously monitors glucose levels and triggers insulin release only when glucose exceeds a threshold. This closed-loop system ensures rapid responsiveness to glucose changes while maintaining reliable glucose control through automated regulation.
Solution Approach 2:
The patent uses glucose-responsive polymers that change their physical or chemical parameters (such as swelling, disassembly, or permeability) in response to glucose concentration changes. This allows the vesicles to rapidly respond to glucose spikes by transitioning from a closed to an open state, releasing insulin quickly when needed.
3Reliability
If conventional insulin delivery methods are used, then insulin administration is achieved, but localized inflammation occurs
Solution Approach 1:
The patent employs self-assembling vesicles that automatically position and deliver insulin without requiring external injection forces. The vesicles self-propel or self-position in the tissue, reducing mechanical trauma and inflammation. The glucose-responsive release mechanism also prevents premature release that could cause inflammatory responses.
Solution Approach 2:
The patent uses composite vesicle structures combining glucose oxidase, responsive polymers, and insulin in a single integrated system. This composite material approach allows controlled release that minimizes tissue irritation while maintaining delivery effectiveness, reducing localized inflammation compared to conventional methods.
4Productivity
If glucose-responsive vesicles with dual sensitivity are used, then rapid and controlled insulin release is achieved, but system complexity increases
Solution Approach 1:
The patent combines glucose sensing, hydrogen peroxide detection, and insulin release functions into a single integrated vesicle system. The dual-sensitive polymer structure incorporates both glucose oxidase and hydrogen peroxide-sensitive moieties, allowing the system to respond to glucose changes while simultaneously managing the hydrogen peroxide byproduct, thus achieving rapid controlled release without proportionally increasing complexity.
Solution Approach 2:
The patent designs vesicles with multi-functional polymers that simultaneously serve as structural components, glucose sensors, hydrogen peroxide sensors, and insulin carriers. This multi-functionality reduces the need for separate components, achieving rapid and controlled insulin release while keeping the overall system complexity manageable through functional integration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides a painless, rapid, and controlled insulin delivery that mimics natural glucose regulation, reducing side effects and improving glycemic control without long-term inflammation.
Implementation Method 1
said hydrogen peroxide-sensitive group comprises a hydrogen peroxide-sensitive moiety that can be oxidized in the presence of hydrogen peroxide to form a hydrophilic moiety
Implementation Method 2
said hypoxia-sensitive hydrophobic group comprises a hypoxia-sensitive moiety that can be reduced in the presence of a hypoxic environment to form a hydrophilic moiety
Implementation Method 3
an amphiphilic polymeric material comprising a polymer conjugated to a hydrogen peroxide-sensitive hydrophobic group and a hypoxia-sensitive hydrophobic group
Data Source
AI summary
A composition comprising an amphiphilic polymeric material that is both hydrogen peroxide- and hypoxia-sensitive is described. The composition can further include a glucose-oxidizing enzyme and insulin, a bioactive derivative thereof, and/or another therapeutic agent (e.g., another diabetes treatment agent). The polymeric material can form vesicles that comprise single or multiple layers of the polymeric material that enclose the glucose-oxidizing enzyme and the insulin, bioactive derivative and/or other therapeutic agent. The vesicles can be loaded into microneedles to, for example, prepare microneedle arrays for skin patches. Methods of delivering insulin to a subject using the compositions, vesicles, microneedles, and/or microneedle array skin patches are also described.